"Metabolically benign" obesity: A wolf in sheep's clothing

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 74-76

  McEvoy, John W ^a   Blaha, Michael J ^a   Nasir, Khurram ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metabolically benign; Obesity

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL OBESITY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; DISEASE DURATION; DISEASE SEVERITY; FRAMINGHAM RISK SCORE; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; METABOLICALLY BENIGN OBESITY; MORTALITY; NOTE; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PULSE WAVE; WAIST HIP RATIO; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS;

EID: 79960272211     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.039     Document Type: Note

References (19)

1. Haslam D., Sattar N., Lean M. ABC of obesity. Obesity - time to wake up. BMJ 2006, 333(Sep 23 (7569)):640-642.
2. Haslam D.W., James W.P. Obesity. Lancet 2005, 366(Oct 1 (9492)):1197-1209.
3. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88.
4. Whitlock G., Lewington S., Sherliker P., et al. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373(Mar 28 (9669)):1083-1096.
5. Wildman R.P., Muntner P., Reynolds K., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168(Aug 11 (15)):1617-1624.
6. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168(Aug 11 (15)):1609-1616.
7. Song Y., Manson J.E., Meigs J.B., Ridker P.M., Buring J.E., Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007, 100(Dec 1 (11)):1654-1658.
8. Kuk J.L., Ardern C.I. Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care 2009, 32(Dec (12)):2297-2299.
9. Khan UI, et al. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: The Study of Women's Health Across the Nation (SWAN). Atherosclerosis (2011), doi:10.1016/j.atherosclerosis.2011.01.007.
10. Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359(Nov 13 (20)):2105-2120.
11. Feller S., Boeing H., Pischon T. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. Dtsch Arztebl Int 2010, 107(Jul (26)):470-476.
12. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(Sep 11-17 (9438)):937-952.
13. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(Dec (12)):1595-1607.
14. Blaha M.J., Bansal S., Rouf R., Golden S.H., Blumenthal R.S., Defilippis A.P. A practical "ABCDE" approach to the metabolic syndrome. Mayo Clin Proc 2008, 83(Aug (8)):932-941.
15. Kuk J.L., Ardern C.I. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 2010, 33(Nov (11)):2457-2461.
16. Brooks G.C., Blaha M.J., Blumenthal R.S. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010, 106(Jul 1 (1)):56-61.
17. Lemieux I., Pascot A., Prud'homme D., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001, 21(Jun (6)):961-967.
18. Sjostrom CD, Lystig T, Lindroos AK. Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study. Int J Obes (Lond) 2011, PMID:21266948. [Epub ahead of print]. doi:10.1038/ijo.2010.282.
19. Tenenbaum A., Fisman E.Z. "The metabolic syndrome... is dead": these reports are an exaggeration. Cardiovasc Diabetol 2011, 10(Jan 27 (1)):11.